バイオシミラー薬物の世界市場レポート2020

• 英文タイトル：Global Biosimilar Drug Sales Market Report 2020

• レポートコード：20QY06-02716 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Multi User	￥888,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,184,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、バイオシミラー薬物のグローバル市場について種類別（注射剤、錠剤、その他）、用途別（強直性脊椎炎、腫瘍、関節リウマチ、循環器、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・バイオシミラー薬物市場の概要 ・世界の主要地域別バイオシミラー薬物市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のバイオシミラー薬物市場規模2015-2026：種類別（注射剤、錠剤、その他） ・世界のバイオシミラー薬物市場規模2015-2026：用途別（強直性脊椎炎、腫瘍、関節リウマチ、循環器、その他） ・バイオシミラー薬物の北米市場規模2015-2020 ・バイオシミラー薬物のヨーロッパ市場規模2015-2020 ・バイオシミラー薬物の中国市場規模2015-2020 ・バイオシミラー薬物の日本市場規模2015-2020 ・バイオシミラー薬物の東南アジア市場規模2015-2020 ・バイオシミラー薬物のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Amgen、、Eli Lilly、、Novartis、、CP Guojian Pharma、、Biotech Pharma、） ・バイオシミラー薬物の製造コスト分析 ・販売チャネル、流通業者、顧客 ・バイオシミラー薬物の市場動向・機会・課題 ・調査の結論

A recently published report by QY Research titled Global Biosimilar Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Biosimilar Drug market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.

QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Report Overview:

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biosimilar Drug market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Biosimilar Drug industry.

Based on our recent survey, we have several different scenarios about the Biosimilar Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biosimilar Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

QY Research report provides an overview and scope of the global Biosimilar Drug market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Biosimilar Drug market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.

QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Biosimilar Drug market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Biosimilar Drug market. The report also includes nautical information, where it shows Biosimilar Drug market product volume, utilization value, and production processes.

The research report also consists of a competitive landscape that describes the top players that are functioning in the global Biosimilar Drug market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Biosimilar Drug market.

As healthcare costs continue to rise, biosimilars offer new therapeutic options with the potential for cost savings to the healthcare system. With anticipated savings, biosimilars bring hope that there will be expanded access for patients to not only these known therapies, but also to new innovative medicines. At Amgen, serving patients is at the core of what we do and it is why we’re using our more than 35 years of biologics experience to develop high-quality biosimilars.

First, in pharmerging markets, both governments and patients struggle to pay for biosimilars, which encouraged the demand of biosimilars, therefore in the future the biosimilars will grow around 20%.

Second, generally, biosimilars industry is still in their infancy in China. It is commonly believed that the next 10 to 15 years is the golden period of the development of biosimilars.

Third, for the biosimilars industry, technical barriers will be much smaller, in the next few years, there will be more and more enterprises going into biosimilars industry.

Forth, most of biosimilars manufacturer are concentrated in US, Germany, UK and other developed countries.

At last, through the research we tend to believe that the biosimilars, now is a chance for newcomers and they will greatly change the industry.

Geographical Analysis:

Based on region, the global Biosimilar Drug market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.

Key Players:

The major players that are operating in the global Biosimilar Drug market are

Amgen

Eli Lilly

Novartis

CP Guojian Pharma

Biotech Pharma

…

Segment by Type

Injection

Tablets

Other Types

Segment by Application

Ankylosing Spondylitis

Tumor

Rheumatoid Arthrtis

Cardiovascular

Other Application

Competitive Landscape:

Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Biosimilar Drug market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.

The report covers the following objectives:

• Proliferation and maturation of trade in the global Biosimilar Drug market.

• The market share of the global Biosimilar Drug market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.

• Current and future market trends that are influencing the growth opportunities and growth rate of the global Biosimilar Drug market.

• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Biosimilar Drug market.

レポート目次

---

1 Biosimilar Drug Market Overview

1.1 Biosimilar Drug Product Scope

1.2 Biosimilar Drug Segment by Type

1.2.1 Global Biosimilar Drug Sales by Type (2020-2026)

1.2.2 Injection

1.2.3 Tablets

1.2.4 Other Types

1.3 Biosimilar Drug Segment by Application

1.3.1 Global Biosimilar Drug Sales Comparison by Application (2020-2026)

1.3.2 Ankylosing Spondylitis

1.3.3 Tumor

1.3.4 Rheumatoid Arthrtis

1.3.5 Cardiovascular

1.3.6 Other Application

1.4 Biosimilar Drug Market Estimates and Forecasts (2015-2026)

1.4.1 Global Biosimilar Drug Sales Growth Rate (2015-2026)

1.4.2 Global Biosimilar Drug Revenue and Growth Rate (2015-2026)

1.4.3 Global Biosimilar Drug Price Trends (2015-2026)

1.5 Coronavirus Disease 2019 (Covid-19): Biosimilar Drug Industry Impact

1.5.1 How the Covid-19 is Affecting the Biosimilar Drug Industry

1.5.1.1 Biosimilar Drug Business Impact Assessment – Covid-19

1.5.1.2 Supply Chain Challenges

1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products

1.5.2 Market Trends and Biosimilar Drug Potential Opportunities in the COVID-19 Landscape

1.5.3 Measures / Proposal against Covid-19

1.5.3.1 Government Measures to Combat Covid-19 Impact

1.5.3.2 Proposal for Biosimilar Drug Players to Combat Covid-19 Impact

2 Biosimilar Drug Estimate and Forecast by Region

2.1 Global Biosimilar Drug Market Size by Region: 2015 VS 2020 VS 2026

2.2 Global Biosimilar Drug Retrospective Market Scenario by Region (2015-2020)

2.2.1 Global Biosimilar Drug Sales Market Share by Region (2015-2020)

2.2.2 Global Biosimilar Drug Revenue Market Share by Region (2015-2020)

2.3 Global Biosimilar Drug Market Estimates and Forecasts by Region (2021-2026)

2.3.1 Global Biosimilar Drug Sales Estimates and Forecasts by Region (2021-2026)

2.3.2 Global Biosimilar Drug Revenue Forecast by Region (2021-2026)

2.4 Geographic Market Analysis: Market Facts & Figures

2.4.1 United States Biosimilar Drug Estimates and Projections (2015-2026)

2.4.2 Europe Biosimilar Drug Estimates and Projections (2015-2026)

2.4.3 China Biosimilar Drug Estimates and Projections (2015-2026)

2.4.4 Japan Biosimilar Drug Estimates and Projections (2015-2026)

2.4.5 Southeast Asia Biosimilar Drug Estimates and Projections (2015-2026)

2.4.6 India Biosimilar Drug Estimates and Projections (2015-2026)

3 Global Biosimilar Drug Competition Landscape by Players

3.1 Global Top Biosimilar Drug Players by Sales (2015-2020)

3.2 Global Top Biosimilar Drug Players by Revenue (2015-2020)

3.3 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Drug as of 2019)

3.4 Global Biosimilar Drug Average Price by Company (2015-2020)

3.5 Manufacturers Biosimilar Drug Manufacturing Sites, Area Served, Product Type

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3.7 Primary Interviews with Key Biosimilar Drug Players (Opinion Leaders)

4 Global Biosimilar Drug Market Size by Type

4.1 Global Biosimilar Drug Historic Market Review by Type (2015-2020)

4.1.1 Global Biosimilar Drug Sales Market Share by Type (2015-2020)

4.1.2 Global Biosimilar Drug Revenue Market Share by Type (2015-2020)

4.1.3 Global Biosimilar Drug Price by Type (2014-2020)

4.2 Global Biosimilar Drug Market Estimates and Forecasts by Type (2021-2026)

4.2.1 Global Biosimilar Drug Sales Forecast by Type (2021-2026)

4.2.2 Global Biosimilar Drug Revenue Forecast by Type (2021-2026)

4.2.3 Global Biosimilar Drug Price Forecast by Type (2021-2026)

5 Global Biosimilar Drug Market Size by Application

5.1 Global Biosimilar Drug Historic Market Review by Application (2015-2020)

5.1.1 Global Biosimilar Drug Sales Market Share by Application (2015-2020)

5.1.2 Global Biosimilar Drug Revenue Market Share by Application (2015-2020)

5.1.3 Global Biosimilar Drug Price by Application (2015-2020)

5.2 Global Biosimilar Drug Market Estimates and Forecasts by Application (2021-2026)

5.2.1 Global Biosimilar Drug Sales Forecast by Application (2021-2026)

5.2.2 Global Biosimilar Drug Revenue Forecast by Application (2021-2026)

5.2.3 Global Biosimilar Drug Price Forecast by Application (2021-2026)

3 North America Biosimilar Drug Market Facts & Figures

3.2 North America Biosimilar Drug Sales Market Share by Company (2015-2020)

3.3 North America Biosimilar Drug Sales Market Share by Type (2015-2020)

3.4 North America Biosimilar Drug Sales Market Share by Application (2015-2020)

4 Europe Biosimilar Drug Market Facts & Figures

4.2 Europe Biosimilar Drug Sales Market Share by Company (2015-2020)

4.3 Europe Biosimilar Drug Sales Market Share by Type (2015-2020)

4.4 Europe Biosimilar Drug Sales Market Share by Application (2015-2020)

5 China Biosimilar Drug Market Facts & Figures

5.2 China Biosimilar Drug Sales Market Share by Company (2015-2020)

5.3 China Biosimilar Drug Sales Market Share by Type (2015-2020)

5.4 China Biosimilar Drug Sales Market Share by Application (2015-2020)

6 Japan Biosimilar Drug Market Facts & Figures

6.2 Japan Biosimilar Drug Sales Market Share by Company (2015-2020)

6.3 Japan Biosimilar Drug Sales Market Share by Type (2015-2020)

6.4 Japan Biosimilar Drug Sales Market Share by Application (2015-2020)

7 Southeast Asia Biosimilar Drug Market Facts & Figures

7.2 Southeast Asia Biosimilar Drug Sales Market Share by Company (2015-2020)

7.3 Southeast Asia Biosimilar Drug Sales Market Share by Type (2015-2020)

7.4 Southeast Asia Biosimilar Drug Sales Market Share by Application (2015-2020)

8 India Biosimilar Drug Market Facts & Figures

8.2 India Biosimilar Drug Sales Market Share by Company (2015-2020)

8.3 India Biosimilar Drug Sales Market Share by Type (2015-2020)

8.4 India Biosimilar Drug Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Biosimilar Drug Business

12.1 Amgen

12.1.1 Amgen Biosimilar Drug Corporation Information

12.1.2 Amgen Biosimilar Drug Business Overview and Total Revenue

12.1.3 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2015-2020)

12.1.4 Amgen Biosimilar Drug Products Offered

12.1.5 Amgen Recent Development

12.2 Eli Lilly

12.2.1 Eli Lilly Biosimilar Drug Corporation Information

12.2.2 Eli Lilly Biosimilar Drug Business Overview and Total Revenue

12.2.3 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2015-2020)

12.2.4 Eli Lilly Biosimilar Drug Products Offered

12.2.5 Eli Lilly Recent Development

12.3 Novartis

12.3.1 Novartis Biosimilar Drug Corporation Information

12.3.2 Novartis Biosimilar Drug Business Overview and Total Revenue

12.3.3 Novartis Biosimilar Drug Sales, Revenue and Gross Margin (2015-2020)

12.3.4 Novartis Biosimilar Drug Products Offered

12.3.5 Novartis Recent Development

12.4 CP Guojian Pharma

12.4.1 CP Guojian Pharma Biosimilar Drug Corporation Information

12.4.2 CP Guojian Pharma Biosimilar Drug Business Overview and Total Revenue

12.4.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2015-2020)

12.4.4 CP Guojian Pharma Biosimilar Drug Products Offered

12.4.5 CP Guojian Pharma Recent Development

12.5 Biotech Pharma

12.5.1 Biotech Pharma Biosimilar Drug Corporation Information

12.5.2 Biotech Pharma Biosimilar Drug Business Overview and Total Revenue

12.5.3 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2015-2020)

12.5.4 Biotech Pharma Biosimilar Drug Products Offered

12.5.5 Biotech Pharma Recent Development

…

13 Biosimilar Drug Manufacturing Cost Analysis

13.1 Biosimilar Drug Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Key Raw Materials Price Trend

13.1.3 Key Suppliers of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.3 Manufacturing Process Analysis of Biosimilar Drug

13.4 Biosimilar Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

14.1 Marketing Channel

14.2 Biosimilar Drug Distributors List

14.3 Biosimilar Drug Customers

15 Market Dynamics

15.1 Market Trends

15.2 Opportunities and Drivers

15.3 Challenges

15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix

17.1 Research Methodology

17.1.1 Methodology/Research Approach

17.1.2 Data Source

17.2 Author List

17.3 Disclaimer

List of Tables

Table 1. Global Biosimilar Drug Sales (K Dose) Growth Rate by Type (2020-2026)

Table 2. Global Biosimilar Drug Sales (K Dose) Comparison by Application (2020-2026)

Table 3. COVID-19 Impact Global Market: (Four Biosimilar Drug Market Size Forecast Scenarios)

Table 4. Opportunities and Trends for Biosimilar Drug Players in the COVID-19 Landscape

Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 6. Key Regions/Countries Measures against Covid-19 Impact

Table 7. Proposal for Biosimilar Drug Players to Combat Covid-19 Impact

Table 8. Global Market Biosimilar Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026

Table 9. Global Biosimilar Drug Sales (K Dose) by Region (2015-2020)

Table 10. Global Biosimilar Drug Sales Market Share by Region (2015-2020)

Table 11. Global Biosimilar Drug Revenue (US$ Million) Market Share by Region (2015-2020))

Table 12. Global Biosimilar Drug Revenue Share by Region (2015-2020)

Table 13. Global Biosimilar Drug Sales (K Dose) Forecast by Region (2021-2026)

Table 14. Global Biosimilar Drug Sales Market Share Forecast by Region (2021-2026)

Table 15. Global Biosimilar Drug Revenue (US$ Million) Forecast by Region (2021-2026)

Table 16. Global Biosimilar Drug Revenue Share Forecast by Region (2021-2026)

Table 17. Global Biosimilar Drug (K Dose) of Key Companies (2015-2020)

Table 18. Global Biosimilar Drug Sales Share by Company (2015-2020)

Table 19. Global Biosimilar Drug Revenue (US$ Million) by Company (2015-2020)

Table 20. Global Biosimilar Drug Revenue Share by Company (2015-2020)

Table 21. Global Biosimilar Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Drug as of 2019)

Table 22. Global Biosimilar Drug Average Price (USD/Dose) of Key Company (2015-2020)

Table 23. Manufacturers Biosimilar Drug Manufacturing Sites and Area Served

Table 24. Manufacturers Biosimilar Drug Product Type

Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 26. Main Points Interviewed from Key Biosimilar Drug Players

Table 27. Global Biosimilar Drug Sales (K Dose) by Type (2015-2020)

Table 28. Global Biosimilar Drug Sales Share by Type (2015-2020)

Table 29. Global Biosimilar Drug Revenue (US$ Million) Market Share by Type (2015-2020)

Table 30. Global Biosimilar Drug Price (K Dose) by Type (2015-2020)

Table 31. Global Biosimilar Drug Sales Share by Type (2021-2026)

Table 32. Global Biosimilar Drug Revenue (US$ Million) Market Share by Type (2021-2026)

Table 33. Global Biosimilar Drug Revenue Share by Type (2021-2026)

Table 34. Global Biosimilar Drug Price (K Dose) by Type (2021-2026)

Table 35. Global Biosimilar Drug Sales (K Dose) by Application (2015-2020)

Table 36. Global Biosimilar Drug Sales Share by Application (2015-2020)

Table 37. Global Biosimilar Drug Revenue (US$ Million) Market Share by Application (2015-2020)

Table 38. Global Biosimilar Drug Price (K Dose) by Application (2015-2020)

Table 39. Global Biosimilar Drug Sales (K Dose) by Application (2021-2026)

Table 40. Global Biosimilar Drug Sales Share by Application (2021-2026)

Table 41. Global Biosimilar Drug Revenue (US$ Million) Market Share by Application (2021-2026)

Table 42. Global Biosimilar Drug Revenue Share by Application (2021-2026)

Table 43. Global Biosimilar Drug Price (K Dose) by Application (2021-2026)

Table 44. United States Biosimilar Drug Sales (K Dose) by Company (2015-2020)

Table 45. United States Biosimilar Drug Sales Market Share by Company (2015-2020)

Table 46. United States Biosimilar Drug Sales (K Dose) by Type (2015-2020)

Table 47. United States Biosimilar Drug Sales Market Share by Type (2015-2020)

Table 48. United States Biosimilar Drug Sales (K Dose) by Application (2015-2020)

Table 49. United States Biosimilar Drug Sales Market Share by Application (2015-2020)

Table 50. Europe Biosimilar Drug Sales (K Dose) by Company (2015-2020)

Table 51. Europe Biosimilar Drug Sales Market Share by Company (2015-2020)

Table 52. Europe Biosimilar Drug Sales (K Dose) by Type (2015-2020)

Table 53. Europe Biosimilar Drug Sales Market Share by Type (2015-2020)

Table 54. Europe Biosimilar Drug Sales (K Dose) by Application (2015-2020)

Table 55. Europe Biosimilar Drug Sales Market Share by Type (2015-2020)

Table 56. China Biosimilar Drug Sales (K Dose) by Company (2015-2020)

Table 57. China Biosimilar Drug Sales Market Share by Company (2015-2020)

Table 58. China Biosimilar Drug Sales (K Dose) by Type (2015-2020)

Table 59. China Biosimilar Drug Sales Market Share by Type (2015-2020)

Table 60. China Biosimilar Drug Sales (K Dose) by Application (2015-2020)

Table 61. China Biosimilar Drug Sales Market Share by Application (2015-2020)

Table 62. Japan Biosimilar Drug Sales (K Dose) by Company (2015-2020)

Table 63. Japan Biosimilar Drug Sales Market Share by Company (2015-2020)

Table 64. Japan Biosimilar Drug Sales (K Dose) by Type (2015-2020)

Table 65. Japan Biosimilar Drug Sales Market Share by Type (2015-2020)

Table 66. Japan Biosimilar Drug Sales (K Dose) by Application (2015-2020)

Table 67. Japan Biosimilar Drug Sales Market Share by Application (2015-2020)

Table 68. Southeast Asia Biosimilar Drug Sales (K Dose) by Company (2015-2020)

Table 69. Southeast Asia Biosimilar Drug Sales Market Share by Company (2015-2020)

Table 70. Southeast Asia Biosimilar Drug Sales (K Dose) by Type (2015-2020)

Table 71. Southeast Asia Biosimilar Drug Sales Market Share by Type (2015-2020)

Table 72. Southeast Asia Biosimilar Drug Sales (K Dose) by Type (2015-2020)

Table 73. Southeast Asia Biosimilar Drug Sales Market Share by Application (2015-2020)

Table 74. India Biosimilar Drug Sales (K Dose) by Company (2015-2020)

Table 75. India Biosimilar Drug Sales Market Share by Company (2015-2020)

Table 76. India Biosimilar Drug Sales (K Dose) by Type (2015-2020)

Table 77. India Biosimilar Drug Sales Market Share by Type (2015-2020)

Table 78. India Biosimilar Drug Sales (K Dose) by Application (2015-2020)

Table 79. India Biosimilar Drug Sales Market Share by Application (2015-2020)

Table 80. Amgen Corporation Information

Table 81. Amgen Description and Business Overview

Table 82. Amgen Biosimilar Drug Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 83. Amgen Biosimilar Drug Product

Table 84. Amgen Recent Development

Table 85. Eli Lilly Corporation Information

Table 86. Eli Lilly Description and Business Overview

Table 87. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 88. Eli Lilly Biosimilar Drug Product

Table 89. Eli Lilly Recent Development

Table 90. Novartis Corporation Information

Table 91. Novartis Description and Business Overview

Table 92. Novartis Biosimilar Drug Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 93. Novartis Biosimilar Drug Product

Table 94. Novartis Recent Development

Table 95. CP Guojian Pharma Corporation Information

Table 96. CP Guojian Pharma Description and Business Overview

Table 97. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 98. CP Guojian Pharma Biosimilar Drug Product

Table 99. CP Guojian Pharma Recent Development

Table . Biotech Pharma Corporation Information

Table . Biotech Pharma Description and Business Overview

Table . Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table . Biotech Pharma Biosimilar Drug Product

Table . Biotech Pharma Recent Development

Table 105. Production Base and Market Concentration Rate of Raw Material

Table 106. Key Suppliers of Raw Materials

Table 107. Biosimilar Drug Distributors List

Table 108. Biosimilar Drug Customers List

Table 109. Market Key Trends

Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)

Table 111. Key Challenges

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Biosimilar Drug Product Picture

Figure 2. Global Biosimilar Drug Sales Market Share by Type in 2020 & 2026

Figure 3. Type I Product Picture

Figure 4. Type II Product Picture

Figure 5. Global Biosimilar Drug Market Share by Application in 2020 & 2026

Figure 6. Ankylosing Spondylitis Examples

Figure 7. Tumor Examples

Figure 8. Rheumatoid Arthrtis Examples

Figure 9. Cardiovascular Examples

Figure 10. Other Application Examples

Figure 11. Global Biosimilar Drug Sales (K Dose) Growth Rate (2015-2026)

Figure 12. Global Biosimilar Drug Revenue (US$ Million) Growth Rate (2015-2026)

Figure 13. Global Biosimilar Drug Price Trends Growth Rate (2015-2026) (USD/Dose)

Figure 14. Global Biosimilar Drug Revenue Market Share by Region: 2015 VS 2020

Figure 15. Global Biosimilar Drug Revenue Market Share by Region: 2021 VS 2026

Figure 16. United States Biosimilar Drug Revenue (Million USD) Growth Rate (2015-2026)

Figure 17. United States Biosimilar Drug Sales (K Dose) Growth Rate (2015-2026)

Figure 18. Europe Biosimilar Drug Revenue (Million USD) Growth Rate (2015-2026)

Figure 19. Europe Biosimilar Drug Sales (Million USD) Growth Rate (2015-2026)

Figure 20. China Biosimilar Drug Revenue (Million USD) Growth Rate (2015-2026)

Figure 21. China Biosimilar Drug Sales (Million USD) and Growth Rate (2015-2026)

Figure 22. Japan Biosimilar Drug Revenue (Million USD) Growth Rate (2015-2026)

Figure 23. Japan Biosimilar Drug Sales (Million USD) Growth Rate (2015-2026)

Figure 24. Southeast Asia Biosimilar Drug Revenue (Million USD) Growth Rate (2015-2026)

Figure 25. Southeast Asia Biosimilar Drug Sales (Million USD) Growth Rate (2015-2026)

Figure 26. India Biosimilar Drug Revenue (Million USD) Growth Rate (2015-2026)

Figure 27. India Biosimilar Drug Sales (Million USD) Growth Rate (2015-2026)

Figure 28. Global 5 Largest Biosimilar Drug Players Market Share by Revenue in Biosimilar Drug 2015 & 2019

Figure 29. Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 30. Global Biosimilar Drug Revenue Share by Type (2015-2020)

Figure 31. Global Biosimilar Drug Revenue Growth Rate by Type in 2015 & 2019

Figure 32. Global Biosimilar Drug Revenue Share by Application (2015-2020)

Figure 33. Global Biosimilar Drug Revenue Growth Rate by Application in 2015 & 2019

Figure 34. United States Biosimilar Drug Sales Market Share by Type in 2019

Figure 35. United States Biosimilar Drug Sales Market Share by Type in 2019

Figure 36. Europe Biosimilar Drug Sales Market Share by Company in 2019

Figure 37. Europe Biosimilar Drug Sales Market Share by Type in 2019

Figure 38. Europe Biosimilar Drug Sales Market Share by Application in 2019

Figure 39. China Biosimilar Drug Sales Market Share by Company in 2019

Figure 40. China Biosimilar Drug Sales Market Share by Type in 2019

Figure 41. China Biosimilar Drug Sales Market Share by Application in 2019

Figure 42. Japan Biosimilar Drug Sales Market Share by Company in 2019

Figure 43. Japan Biosimilar Drug Sales Market Share by Type in 2019

Figure 44. Japan Biosimilar Drug Sales Market Share by Application in 2019

Figure 45. Southeast Asia Biosimilar Drug Sales Market Share by Company in 2019

Figure 46. Southeast Asia Biosimilar Drug Sales Market Share by Type in 2019

Figure 47. Southeast Asia Biosimilar Drug Sales Market Share by Application in 2019

Figure 48. India Biosimilar Drug Sales Market Share by Company in 2019

Figure 49. India Biosimilar Drug Sales Market Share by Type in 2019

Figure 50. India Biosimilar Drug Sales Market Share by Application in 2019

Figure 51. Amgen Total Revenue (US$ Million): 2019 Compared with 2018

Figure 52. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018

Figure 53. Novartis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 54. CP Guojian Pharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 55. Biotech Pharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 56. Key Raw Materials Price Trend

Figure 57. Manufacturing Cost Structure of Biosimilar Drug

Figure 58. Manufacturing Process Analysis of Biosimilar Drug

Figure 59. Biosimilar Drug Industrial Chain Analysis

Figure 60. Channels of Distribution

Figure 61. Distributors Profiles

Figure 62. Porter's Five Forces Analysis

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

---